DK0708103T3 - Fremgangsmåde til fremstilling af et tetrazolderivat i to krystallinske former og ny krystallinsk form af dette derivat - Google Patents

Fremgangsmåde til fremstilling af et tetrazolderivat i to krystallinske former og ny krystallinsk form af dette derivat

Info

Publication number
DK0708103T3
DK0708103T3 DK95402322T DK95402322T DK0708103T3 DK 0708103 T3 DK0708103 T3 DK 0708103T3 DK 95402322 T DK95402322 T DK 95402322T DK 95402322 T DK95402322 T DK 95402322T DK 0708103 T3 DK0708103 T3 DK 0708103T3
Authority
DK
Denmark
Prior art keywords
derivative
water
ray diffraction
diffraction pattern
contg
Prior art date
Application number
DK95402322T
Other languages
English (en)
Inventor
Antoine Caron
Dominique Chantreux
Colette Residence Le Bouloumie
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of DK0708103T3 publication Critical patent/DK0708103T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
DK95402322T 1994-10-19 1995-10-18 Fremgangsmåde til fremstilling af et tetrazolderivat i to krystallinske former og ny krystallinsk form af dette derivat DK0708103T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9412459A FR2725987B1 (fr) 1994-10-19 1994-10-19 Procede pour la preparation d'un derive de tetrazole sous deux formes cristallines et nouvelle forme cristalline de ce derive

Publications (1)

Publication Number Publication Date
DK0708103T3 true DK0708103T3 (da) 2001-04-23

Family

ID=9467986

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95402322T DK0708103T3 (da) 1994-10-19 1995-10-18 Fremgangsmåde til fremstilling af et tetrazolderivat i to krystallinske former og ny krystallinsk form af dette derivat

Country Status (26)

Country Link
US (1) US5629331A (da)
EP (1) EP0708103B1 (da)
JP (1) JP3366786B2 (da)
KR (1) KR100251222B1 (da)
CN (1) CN1061656C (da)
AT (1) ATE198478T1 (da)
AU (1) AU698041B2 (da)
CA (1) CA2160725C (da)
CY (1) CY2277B1 (da)
CZ (2) CZ288629B6 (da)
DE (1) DE69519788T2 (da)
DK (1) DK0708103T3 (da)
ES (1) ES2155115T3 (da)
FI (1) FI114156B (da)
FR (1) FR2725987B1 (da)
GR (1) GR3035503T3 (da)
HU (1) HU226461B1 (da)
IL (1) IL115688A (da)
NO (1) NO307516B1 (da)
NZ (1) NZ280293A (da)
PL (1) PL184193B1 (da)
PT (1) PT708103E (da)
RU (1) RU2144536C1 (da)
SI (1) SI0708103T1 (da)
TW (1) TW357147B (da)
ZA (1) ZA958850B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW442301B (en) * 1995-06-07 2001-06-23 Sanofi Synthelabo Pharmaceutical compositions containing irbesartan
US5994348A (en) * 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
FR2780403B3 (fr) * 1998-06-24 2000-07-21 Sanofi Sa Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
PT1094816E (pt) 1998-07-06 2009-03-10 Bristol Myers Squibb Co Sulfonamidas bifenílicas duplamente antagonistas receptores de angiotensina e endotelina
BR0112665A (pt) * 2000-07-19 2003-06-24 Novartis Ag Sais
US20050176793A1 (en) * 2001-12-10 2005-08-11 Reddy Reguri B. Amorphous form of 2-n-butyl-3-((2-(1h-tetrazol-5-yl)([1,1'-biphenyl)-4-yl)methyl)-1, 3-diazaspiro(4,4')non-1-en-4-one
DE60308708T2 (de) * 2002-07-16 2007-08-23 Teva Pharmaceutical Industries Ltd. Neue synthese von irbesartan
WO2004065383A2 (en) * 2003-01-16 2004-08-05 Teva Pharmaceutical Industries Ltd. Novel synthesis of irbesartan
DE602004015071D1 (de) * 2003-02-05 2008-08-28 Teva Pharma Synthese von 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspiro-4,4 -nonen-4-on
AU2003242984A1 (en) * 2003-04-07 2004-11-01 Hetero Drugs Limited A novel crystalline form of irbesartan
PL379420A1 (pl) * 2003-07-31 2006-09-04 Nicox S.A. Pochodne blokerów receptora angiotensyny II
TW200526638A (en) * 2003-10-22 2005-08-16 Smithkline Beecham Corp 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1H-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline
WO2005051943A1 (en) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited Processes for the preparation of highly pure irbesartan
CA2568640C (en) 2004-06-04 2011-08-09 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing irbesartan
WO2006001026A1 (en) * 2004-06-23 2006-01-05 Hetero Drugs Limited Irbesartan polymorphs
SI21849A (sl) * 2004-07-29 2006-02-28 Krka, Tovarna Zdravil, D.D., Novo Mesto Priprava hidrokloridnih soli tetrazolskega derivata
TWI346108B (en) * 2004-08-23 2011-08-01 Bristol Myers Squibb Co A method for preparing irbesartan and intermediates thereof
GB2419592A (en) * 2004-10-26 2006-05-03 Cipla Ltd Process for the preparation of irbesartan hydrochloride
WO2006050923A1 (en) * 2004-11-11 2006-05-18 Lek Pharmaceuticals D.D. Polymorph form of irbesartan
ES2259909B1 (es) * 2005-02-28 2007-06-16 Inke, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo y de su intermedio de sintesis.
WO2007013101A1 (en) * 2005-07-27 2007-02-01 Jubilant Organosys Limited PROCESS FOR PRODUCING 2-(N-BUTYL)-3-[[2'-(TETRAZOL-5-YL)BIPHENYL- 4-YL]METHYL]-l,3-DIAZASPIRO[4.4] NON-1-EN-4-ONE
PL1806130T3 (pl) 2006-01-09 2010-08-31 Krka D D Novo Mesto Kompozycja farmaceutyczna w postaci stałej zawierająca irbesartan
WO2008041957A1 (en) * 2006-10-03 2008-04-10 Ulkar Kimya Sanayi Ve Ticaret As Method for producing pure crystalline form of 2-n-butyl-3-((2-(1h-tetrazole-5-yl) (1,1'-biphenyl)-4-methyl)-1,3-diazapspiro (4,4') non -1- en-4-one
EP1918288A1 (en) 2006-11-02 2008-05-07 Cadila Pharmaceuticals Limited A novel and improved process for the preparation of Irbesartan, an angiotensin-II receptor antagonist for the treatment of hypertension
PT2065035E (pt) 2007-11-28 2010-10-04 Lesvi Laboratorios Sl Formulações farmacêuticas contendo irbesartan
EP2215083A2 (en) * 2007-12-07 2010-08-11 Hetero Drugs Limited Process for pure irbesartan
KR101009383B1 (ko) * 2008-04-30 2011-01-19 켐젠주식회사 고순도의2-부틸-3-[[2'-(1에이취-테트라졸-5-일)[1,1'-비페닐]-4-일]메틸]-1,3-디아자스피로[4.4]논-1-엔-4-온 화합물의제조방법
EP2417110B1 (en) * 2009-04-08 2014-05-07 CTX Life Sciences Pvt. Ltd. A one pot process for preparing 2-butyl-3-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro [4, 4]non-1-en-4-one (irbesartan)
AR078107A1 (es) * 2009-08-31 2011-10-12 Sanofi Aventis Uso de irbesartan para la preparacion de un medicamento para la prevencion de la hospitalizacion por insuficiencia cardiaca
US8080670B2 (en) 2010-05-04 2011-12-20 Divi's Laboratories, Ltd. Process for the preparation of irbesartan
FR2977253B1 (fr) 2011-06-30 2013-08-09 Centre Nat Rech Scient Reactif organostannique alcoxyle supporte, preparation et utilisation pour la synthese de tetrazoles en phase heterogene
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
US11655220B2 (en) 2020-10-22 2023-05-23 Hetero Labs Limited Process for the preparation of angiotensin II receptor blockers
EP4408836A1 (en) 2021-10-01 2024-08-07 Sanofi Process for preparing sartan active compounds having a tetrazole ring

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2697919B2 (ja) * 1989-09-29 1998-01-19 キヤノン株式会社 信号内挿回路及び該回路を備えた変位測定装置
IE70593B1 (en) * 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same
US5104891A (en) * 1989-12-11 1992-04-14 G. D. Searle & Co. Cycloheptimidazolone compounds as angiotensin ii antagonists for control of hypertension
PT97078B (pt) * 1990-03-20 1997-07-31 Sanofi Sa Processo para a preparacao de derivados heterociclicos n-substituidos e de composicoes farmaceuticas que os contem
IL99372A0 (en) * 1990-09-10 1992-08-18 Ciba Geigy Ag Azacyclic compounds
FR2673427B1 (fr) * 1991-03-01 1993-06-18 Sanofi Elf Derives heterocycliques diazotes n-substitues par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
NZ280293A (en) 1997-10-24
FR2725987A1 (fr) 1996-04-26
CZ271095A3 (en) 1996-05-15
SI0708103T1 (en) 2001-04-30
CZ288624B6 (cs) 2001-08-15
US5629331A (en) 1997-05-13
NO954154L (no) 1996-04-22
CN1061656C (zh) 2001-02-07
CY2277B1 (en) 2003-07-04
HUT73179A (en) 1996-06-28
NO307516B1 (no) 2000-04-17
FI114156B (fi) 2004-08-31
ATE198478T1 (de) 2001-01-15
PL184193B1 (pl) 2002-09-30
CZ288629B6 (cs) 2001-08-15
EP0708103B1 (fr) 2001-01-03
HU9503016D0 (en) 1995-12-28
EP0708103A1 (fr) 1996-04-24
FI954992L (fi) 1996-04-20
GR3035503T3 (en) 2001-06-29
AU698041B2 (en) 1998-10-22
IL115688A (en) 1999-09-22
RU2144536C1 (ru) 2000-01-20
JPH08208642A (ja) 1996-08-13
PT708103E (pt) 2001-06-29
CA2160725A1 (en) 1996-04-20
KR100251222B1 (ko) 2000-05-01
HU226461B1 (en) 2008-12-29
NO954154D0 (no) 1995-10-18
IL115688A0 (en) 1996-01-19
CA2160725C (en) 2001-12-18
ES2155115T3 (es) 2001-05-01
FI954992A0 (fi) 1995-10-19
CN1128261A (zh) 1996-08-07
DE69519788D1 (de) 2001-02-08
HK1005135A1 (en) 1998-12-24
JP3366786B2 (ja) 2003-01-14
PL311012A1 (en) 1996-04-29
ZA958850B (en) 1996-05-27
DE69519788T2 (de) 2001-08-30
KR960014122A (ko) 1996-05-22
FR2725987B1 (fr) 1997-01-10
TW357147B (en) 1999-05-01
AU3433595A (en) 1996-05-02

Similar Documents

Publication Publication Date Title
NO954154L (no) Fremgangsmåte for fremstilling av et tetrazolderivat i to krystallinske former og ny krystallinsk form av nevnte derivat
RU95118109A (ru) Способ получения производного тетразола, способ получения формы b производного тетразола, форма b производного тетразола и фармацевтическая композиция на основе производного тетразола формы b
PT865281E (pt) Derivados de benzimidazole substituidos por naftilo como anticoagulantes
DK0793656T3 (da) Hidtil ukendte benzyl-pyrimidiner
NO973813L (no) Fremgangsmåte ved gjenvinning av xylose fra opplösninger
FR2804935B1 (fr) Procede et installation de recuperation d'effluents en mer
NO941857L (no) Tetrazolylfenylborsyremellomprodukter for syntese av AII-reseptorantagonister
EA200600046A1 (ru) Производные 6-[2-(фосфонометокси)алкокси]пиримидинов (варианты), способ их получения (варианты), фармацевтическая композиция на их основе и способ лечения вирусной инфекции
RU2004128935A (ru) Способ получения производных фенилаланина и их полупродуктов
ATE243685T1 (de) Verfahren zur herstellung von 2-chlor-5- chlormethylthiazol
ATE264323T1 (de) Heterocyclische verbindungen und ihre verwendung als angiotensin ii antagonisten
AU764260B2 (en) Method of producing cyclene
NO930205D0 (no) Benzimidazoler, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
NO983285D0 (no) Pyrido-1,2,4-tiadiazin- og pyrido-1,4-tiazinderivater, deres fremstilling og anvendelse
US6156890A (en) Process for the production of cyclene
ES2071135T3 (es) Procedimientos selectivos para polimorfos de fosinopril.
KR20070110617A (ko) 로사탄의 개선된 제조방법
FR2847571B1 (fr) Dessalement de l'eau de mer par un procede geothermique
Pagoria Synthesis of pure RDX
FR2808844B1 (fr) Systeme permettant la recuperation de l'energie de la mer (houle)
ATE12767T1 (de) Substituierte oximinoacetanilide, verfahren zu ihrer herstellung sowie ihre verwendung als schaedlingsbekaempfungsmittel.
IDP000010651A (id) Sistem pengeboran berputar yang dapat dikemudikan yang terkendali secara aktif serta metode pengeboran sumur